Market Movers, June.06

Trump Warns He Could Raise Tariffs Another $300 Billion, CNBC reports

Dow futures up 68 points 8:26am

VTVT up 30% on 300 000 shares traded, 80% owned by MacAndrews & Forbes Incorporated, a Ronald Perelman company

From PR “Announced positive results from the primary analysis of Part 1 of the Phase 2 Simplici-T1 trial assessing the liver-selective glucokinase activator TTP399 in adult patients with type 1 diabetes (T1D). In this double-blind, placebo-controlled 12-week trial, the baseline mean HbA1c for the groups treated with TTP399 and placebo was 7.3% and 7.4%, respectively. Patients treated with TTP399 (n=8) showed a statistically significant mean reduction in HbA1c of 0.6% at 12 weeks, while the group treated with placebo (n=11) showed a mean increase in HbA1c of 0.1%, resulting in a mean difference of 0.7% in the TTP399 group relative to the placebo group (p=0.03). At the same time, trends toward decreased insulin usage were observed in the group treated with TTP399”. Read more

Stitch Fix beats on sales, up 30% on 300 000 shares traded in the premarket, Bloomberg reports

Ciena Reports Fiscal Second Quarter 2019 Financial Results, up 8% in the premarket on 200 000 shares traded.

  • Q2 Revenue: $865.0 million, increasing 18.5% year over year
  • Q2 Net Income per Share: $0.33 GAAP; $0.48 adjusted (non-GAAP)
  • Share Repurchases: Repurchased approximately 1.2 million shares of common stock for an aggregate price of $45.4 million during the quarter. Full report

At Home Group Inc. down 36% on 700 000 shares traded, Marketwatch reports

Cloudera, Inc. (CLDR) Reports Q1 Loss, Misses Revenue Estimates, down 36% on 700 000 shares traded, Zacks

CTRB up 118% after announcing trails for their CRV431, a novel cyclophilin inhibitor, “significantly decreased the extent of fibrosis in a second animal model of liver fibrosis. Fibrosis, or scarring, of the liver is a hallmark symptom of NASH that results in impaired liver function. Obeticholic acid (“OCA”), a semi-synthetic bile acid analogue drug approved for the treatment primary biliary cholangitis (“PBC”) and being evaluated in Phase 3 trials by another company, was used as a comparator drug in the study and did not decrease the extent of fibrosis in this study conducted by ContraVir“. Link to PR


Below is a list of the ownership structure

On June.03rd, they approved a 1-70 reverse split

S-1/A’ on 4/18/19

‘424B4’ on 4/26/19

 ‘S-1/A’ on 6/4/19 (click image to read filing)

Looks like some shorts covering and momentum traders are driving the price action with InflaRx N.V. today. Makes you wonder if somebody took a position before the news. Up 13% on 2.3 million traded

Medicine Man Technologies, Inc. Charlotte’s Web Holdings, Inc. KushCo Holdings, Inc. Harvest Health & Recreation Inc. and Curaleaf Holdings, Inc. are all up today. Marijuana stocks have been hot this week.

AMD gets rating upgrade from Morgan Stanley, currently at the top of the volume list with 51 million shares traded, up 5%, CNBC reports!

INSYS settles lawsuit for bribing doctors. Pays $225 million in damages, currently up 50%!! Read today’s 8k here

La Jolla Pharmaceutical Company Announces Positive Results from Pre-Specified Interim Analysis of Phase 2 Study of LJPC-401 in Patients with Hereditary Hemochromatosis…..up 42.86% on 1.647M shares traded so far….Read more

CNBC reports: Experian says the average amount borrowed for a new and used vehicle reached a record high of $32,187 and $20,137, respectively. “We have not seen a slowdown in loan demand. In fact, volume for new and used loans is up from previous years,” said Melinda Zabritski, senior director of automotive financial solutions for Experian. Read more

Dow up 49.42  points at lunch, IXIC down -0.13%

Dow closes up 180 points for it’s fourth green day in a row. Read more at CNBC

Stay tuned for more!!

Leave a Reply

%d bloggers like this: